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Pseudomonas aeruginosa poses a serious risk in individuals suffering from cystic fibrosis (CF). Strains
colonizing the CF lung are generally motile but frequently convert to a nonmotile phenotype as the disease
progresses. In many cases, this is coordinately regulated with the overproduction of the exopolysaccharide
alginate. Both the expression of alginate (mucoidy) and the loss of flagellum synthesis may provide the
bacterium with a selective advantage in the CF lung. Previously published data showed that the regulation of
alginate production and flagellum biosynthesis in the CF isolate FRD1 is inversely controlled by the alternative
sigma factor AlgT. In this study, we observed that in CF isolates, the mucoid and the nonmotile phenotypes
occur predominantly together. Using microarrays, we compared the transcriptomes of isogenic AlgT and
AlgT P. aeruginosa and discovered that AlgT significantly downregulated the majority of flagellar genes. A
pronounced inhibitory effect was observed in several genes essential for proper flagellum expression, including
fleQ, which encodes an essential flagellar regulator. The microarray data were confirmed by reverse transcrip-
tase PCR analysis and promoter fusion assays in isogenic AlgT and AlgT strains. Transmission electron
microscopy, motility assays, and Western blots showed that ectopic expression of FleQ in mucoid, nonmotile
CF isolates restored flagellum biosynthesis and motility. Together, these data show that AlgT mediates the
negative control of flagellum expression by inhibiting the expression of the flagellar regulator fleQ.
The gram-negative bacterium Pseudomonas aeruginosa is a
ubiquitous environmental organism. As an opportunistic
pathogen, it rarely causes disease in healthy individuals but
poses a serious risk to those with compromised immune sys-
tems and to cystic fibrosis (CF) patients. P. aeruginosa has an
arsenal of virulence factors, including elastase, hemolysin, en-
dotoxin, type III secretion system proteins, type IV pili, the
exopolysaccharide alginate, and flagella (24, 43). In acute in-
fections, flagella are essential for P. aeruginosa pathogenesis.
This has been documented in a murine thermal injury model in
which nonmotile strains were dramatically attenuated in their
virulence. Whereas motile strains were able to spread rapidly
throughout the host, nonmotile variants were restricted to the
site of inoculation and easily cleared (18). Flagella also play a
critical role in the development of biofilms, where they aid in
initial surface adhesion as well as biofilm dispersal (35, 39). In
addition, soluble flagellin is released by motile gram-negative
bacteria and acts as a potent inducer of inflammation through
interaction with Toll-like receptor 5 (25, 37). Flagellin activates
the NF-B arm of the immune system and provokes the release
of proinflammatory mediators such as tumor necrosis factor,
interleukin 6, interleukin 8, and nitric oxide by macrophages,
monocytes, and epithelial cells (14, 27, 37).
The bacterial flagellum is comprised of two substructures:
the membrane-spanning hook-basal body and an external fil-
ament. The biosynthesis and assembly of a functional flagellum
are subject to a highly complex and tightly controlled regula-
tory cascade which requires coordinate expression of approx-
imately 50 genes encoding structural subunits, regulatory pro-
teins, motor force generators, and chemosensory machinery
(5). In P. aeruginosa, flagellar genes are clustered in three
distinct regions of the chromosome, and a four-tiered tran-
scriptional regulatory circuit controls flagellum synthesis (15).
The FleQ protein, an NtrC-like transcriptional activator, has
been referred to as the master regulator of this pathway, as it
belongs to the top tier of the intricate flagellar hierarchy and is
required for the expression of all other known flagellar genes
with the exception of fliA (8, 15, 29).
In the case of chronic CF pulmonary infections, P. aerugi-
nosa strains initially colonizing the lung are likely derived from
the environment and generally have a motile phenotype (32).
Flagellar components have been shown to bind to airway mu-
cins and are necessary in establishing infection (6, 7, 42). How-
ever, as the disease progresses, the initially motile strains fre-
quently convert to a nonmotile phenotype. Loss of the flagellar
structure may reduce the release of inflammatory mediators by
the host immune system and thus offer P. aeruginosa a selective
advantage in the CF lung (14). Interestingly, the nonmotile
phenotype of P. aeruginosa is found almost exclusively in CF
isolates (32). In many cases, the loss of the flagellum is coor-
dinately regulated with the overproduction of the exopolysac-
charide alginate, thus yielding mucoid, nonmotile variants of P.
aeruginosa. Previously published data revealed that in the CF
isolate FRD1 (mucA22), alginate and flagellum biosynthesis
are inversely regulated by the alternative sigma factor AlgT
(AlgU, 22) (23). While the role of AlgT in the biosynthesis of
alginate is well understood (24, 38), not much is known about
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how AlgT regulates flagellum expression. It has been shown
that in motile, nonmucoid P. aeruginosa strains, the activity of
AlgT is minimal due to the inhibitory effect of the anti-sigma
factor MucA (24, 50). However, in the majority of CF isolates,
including most of those examined in this study, mucA is inac-
tivated due to mutations that occur in vivo, which ultimately
leads to a deregulation of AlgT (24).
The goal of this study was to determine if the AlgT-mediated
inhibition of flagellum biosynthesis is common in mucoid P.
aeruginosa CF isolates and to identify the target(s) of AlgT
within the flagellar regulatory hierarchy. We observed that
70% of mucoid CF isolates tested lacked flagella, and in all
representative strains examined, AlgT was required for this
repression. Microarray analysis, reverse transcriptase (RT)-
PCR, and promoter fusion assays revealed that the expression
of most genes of the flagellar regulon was significantly down-
regulated in the presence of AlgT, and fleQ was identified as
the earliest target of AlgT within the flagellar hierarchy. To
test whether the negative control of fleQ expression by AlgT is
sufficient to account for the lack of flagella in mucoid CF
isolates, FleQ was ectopically expressed in mucoid, nonflagel-
lated P. aeruginosa isolates. The results obtained by Western
blot analysis, motility assays, and transmission electron micros-
copy (TEM) indicated that increased expression of FleQ re-
versed the AlgT-mediated inhibition of flagellum expression in
CF isolates. Together, these data suggest that the AlgT-medi-
ated repression of P. aeruginosa flagellum biosynthesis is a
common regulatory mechanism in mucoid CF isolates and
occurs by inhibiting expression of the flagellar master regulator
fleQ.
MATERIALS AND METHODS
Strains, plasmids, and oligonucleotides. P. aeruginosa PAK, PAKQ (kindly
supplied by R. Ramphal), PAO1, WFPA50 (PAO1 fliC::xylE-aacC1), FRD1
(mucA22), FRD440 (mucA22 algT::Tn501), FRD2700 (attB::pBAD-fleQ), and
PAKQ/pAT6 (attB::pBAD-fleQ) were used for this study. Other P. aeruginosa
strains used included mucoid, nonmotile CF isolates CF1, CF2, and CF3 and
their isogenic algT mutants, as well as a collection of other CF-derived mucoid
strains (9, 47). Escherichia coli strain JM109 (Promega) was utilized for all
cloning experiments. Strains SM10 and HB101/pRK2013 (19) were used to
transfer plasmids to P. aeruginosa. Oligonucleotides used in this study are listed
in Table 1.
Plasmid pSW218 was generated by amplifying omlA by PCR with primers
omlAF and omlAR, cutting the product with SmaI, and ligating the resulting
fragment into the corresponding site of pBluescript II KS()1. Plasmid pAT3
(omlA::lacZ) was generated by cutting pSW218 with EcoRI and BamHI and
cloning the excised omlA promoter fragment into the corresponding restriction
sites of mini-CTX lacZ (10). Plasmid pAT2 (fleQ::lacZ) was generated by cutting
placQ (8) with EcoRI and BamHI and cloning the resulting fragment into the
corresponding restriction sites of mini-CTX lacZ. Plasmid pAT6 was generated
by amplifying fleQ by PCR with primers fleQ5 and fleQ6 (Table 1). The PCR
product was cut with EcoRI and SmaI and cloned into the corresponding sites of
pSW195 (48). The three plasmids were tested for the correct insert by sequenc-
ing. Plasmid pFlp2 (26) was used to excise unwanted mini-CTX lacZ vector
sequences from fusions that were integrated into the P. aeruginosa chromosome.
Plasmid pJF15 (20) contains a functional copy of the algT gene and was used for
complementation analysis.
Media, antibiotics, and enzyme assays. Luria broth (LB; 10 g tryptone/liter, 5 g
yeast extract/liter, 5 g NaCl/liter) and LBNS (LB without NaCl) were used
throughout the study. In addition, LB and LBNS agar plates (broth and 15 g
agar/liter) were used. Plasmids used in this study were maintained in E. coli by
antibiotic selection with 15 g/ml of tetracycline, 100 g/ml of ampicillin, and 30
g/ml of kanamycin. For P. aeruginosa, antibiotics were used at 100 g/ml of
tetracycline and 300 g/ml of carbenicillin. For counterselection, sucrose (5%)
and Irgasan (25 g/ml) were used. For experiments that involved ectopic expres-
sion of FleQ, media were supplemented with 0.1 to 2.5% arabinose. The -ga-
lactosidase assays were performed using o-nitrophenyl--D-galactopyranoside
(ONPG) as a substrate (33). Promoter activity was calculated in amounts of
ONPG hydrolyzed per minute as a function of cell density with the following
equation: units 	 1,000 
 OD420  (1.75 
 OD550)/t 
 V 
 OD600 (where t is
the time in minutes, V is the volume in ml, and ODn is the optical density at n
nm).
Transcriptional profiling. For transcriptional profiling, strain FDR1
(mucA22) and the isogenic algT mutant FRD440 (mucA22 algT::Tn501) were
used. Overnight bacterial cultures were diluted to a starting OD600 of 0.01 in 25
ml of LB and grown with shaking (300 rpm) at 37°C under aerobic conditions.
When cultures reached an OD600 of 0.5 (mid-exponential growth phase), 1.5 ml
of culture (approximately 7.5 
 108 bacteria) was centrifuged at high speed in a
microcentrifuge for 1 min. The bacterial pellet was suspended in 100 l of
lysozyme solution (1 mg/ml; Sigma) and incubated at room temperature for 5
min. RNA was purified from the lysed bacterial fraction with a commercially
available RNeasy Mini RNA purification kit (bacterial protocol; QIAGEN).
RNA samples were eluted with 80 l of RNase-free distilled water and treated
with 10 l of RQ1 DNase (Promega) for 1 h at 37°C. A second purification was
performed using an RNeasy Mini kit (RNA cleanup protocol) followed by
elution in 60 l of RNase-free distilled water. cDNA was synthesized, converted
to cDNA targets, and hybridized to GeneChip P. aeruginosa genome arrays
(Affymetrix) as described previously (46).
Microarray analysis. Hybridization intensity data were extracted from the
scanned array images, and intrachip normalizations were performed using Af-
fymetrix Microarray Suite 5.0 software. In order to eliminate noise, we discarded
those genes that yielded “absent” or “marginal” calls (based on the default
setting in Microarray Suite 5.0) for both strains. The remaining transcripts that
showed greater-than-threefold changes in mRNA levels were considered candi-
date AlgT-regulated genes (see Table S1 in the supplemental material). The
summary of the entire microarray data set is provided in Table S2 in the sup-
plemental material.
Generation of FRD2700 and PAKQ/pAT6. Vector pAT6 was transferred into
P. aeruginosa FRD1 or PAKQ by a triparental spot mating (7 l of an overnight
culture of HB101/pRK2013, 7 l of an overnight culture of JM109/pAT6, 2 l of
an overnight culture of FRD1 or PAKQ), which was done by incubation at 37°C
for 7 h. Colonies were subsequently streaked onto selective media containing
tetracycline and Irgasan. Positive clones were verified for integration of the
vector by PCR using primers CTX1 and attB2 (Table 1). Vector sequences were
TABLE 1. Oligonucleotides used in this study



























a RT indicates primers used in RT-PCRs.
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removed using pFlp2 (49). Final clones were screened by PCR analysis using
primers attB4 and attB5 (Table 1) (49).
Genomic DNA isolation and PCR assay. P. aeruginosa genomic DNA was
purified with Wizard genomic DNA isolation reagents by following instructions
from the manufacturer (Promega). PCR assays were performed in 10-l reaction
mixtures containing 100 to 150 ng of genomic DNA, the appropriate primers (0.5
l of 50-ng/l primer stocks) listed in Table 1, and Taq 2
 Master Mix (Pro-
mega). PCRs involved 30 cycles (94°C/1 min, 55°C/1 min, and 72°C/1 min).
Total RNA isolation and RT-PCR assay. P. aeruginosa total RNA was purified
with Ambion RNA isolation reagents by following instructions from the manu-
facturer (Ambion). A 5-l volume of the isolated RNA was resolved on a 1%
agarose gel at 100 V for 10 min to validate the purity of RNA. RNA was
converted to cDNA using SuperScript II RT (Invitrogen) as described by the
manufacturer. Following this, PCRs with 10-l portions of FRD1 and FRD440
cDNA were performed with 0.5 l cDNA, the appropriate primers (0.5 l of
50-ng/l primer stocks) listed in Table 1, and Taq 2
 Master Mix (Promega).
The PCRs involved 25 cycles (94°C/1 min, 55°C/1 min, and 72°C/1 min) for all
samples except for fliC cDNA (30 cycles under the same conditions). The reac-
tion products were resolved on a 0.7% agarose gel. Band intensities were deter-
mined using a Kodak Image Station 2000RT system.
Static growth experiments and isolation of algT mutants. For the static growth
experiments (17, 48), an overnight shaking culture of mucoid, nonmotile P.
aeruginosa was diluted 1:100 in 5 ml LBNS. The cultures were placed into test
tube racks and incubated statically at 37°C for 96 h. The cultures were briefly
vortexed, tenfold dilutions were performed, and 100-l aliquots were plated onto
LBNS agar plates. Nonmucoid colonies were isolated and complemented with
pJF15 (algT) (20). Clones that reverted back to the mucoid phenotype were
selected and cured of pJF15 by passing on nonselective media. The algT gene was
amplified by PCR using primers algT1 and algT2 and sequenced.
Flagellum-mediated motility assays. For flagellum-mediated motility assays,
bacteria were stab inoculated onto 0.3% motility agar (0.3% agar in LBNS).
Arabinose (0.1 or 2.5%) was added when indicated. Motility plates were incu-
bated overnight at 37°C. Motility was assessed by measuring the diameters of the
circular zones that the colonies spread from their points of inoculation (7).
Bacteria were considered motile if their zone of motility was 5 mm (7).
TEM. Bacteria were grown in LBNS with or without arabinose to an OD600 of
0.5. Formvar-coated copper grids were hydrophilized by immersion in 100%
ethanol. One drop of bacterial culture was added per grid. After 1 min, excess
liquid was wicked off without completely drying the grid to avoid flagellum
shearing. Grids were washed twice by floating them on ultrapure water. Subse-
quently, a drop of 2% uranyl acetate was added and wicked off after 1 min. TEM
was performed on a Philips 400 transmission electron microscope operated at 80
kV.
Western blotting. Western blotting was performed using whole-cell lysates.
The lysates were prepared from P. aeruginosa grown in LBNS with or without
arabinose to an OD600 of 0.5. A 1-ml volume of cells was centrifuged for 3 min
at 14,000 rpm, and the pellet was resuspended in 100 l FB (10 mM Tris-HCl,
pH 8.0, 100 mM NaCl, 1 mM MgCl2). A 10-l (see Fig. 1 and 2) or 25-l (see
Fig. 6) volume of each suspension was examined by Western blotting. Rabbit
anti-flagellin serotype A and anti-flagellin serotype B antiserum (23) were used
at dilutions of 1:20,000. Horseradish peroxidase-conjugated donkey anti-rabbit
immunoglobulin (Amersham Biosciences) was used as the secondary antibody at
a dilution of 1:10,000. The blot was developed using SuperSignal West Dura
extended-duration substrate (Pierce) and exposed to film for 5 to 30 s prior to
development.
RESULTS
The majority of mucoid P. aeruginosa CF isolates do not
express flagellin. The vast majority (98%) of P. aeruginosa
isolates recovered from the environment or acute infections
have a nonmucoid, motile phenotype (32). In contrast, P.
aeruginosa strains obtained from chronic infections in the CF
lung often display a mucoid and/or nonmotile phenotype. The
mucoid phenotype has been attributed to the overexpression of
the exopolysaccharide alginate upon deregulation of the alter-
native sigma factor AlgT (16, 24, 38). In addition, AlgT is
required for the negative regulation of flagellum expression in
the CF isolate FRD1 (mucA22) (23). We hypothesized that in
CF isolates, the alginate phenotype and loss of flagellum ex-
pression are coordinately controlled. To address this, 20 mu-
coid CF isolates were examined for the presence of flagellin by
Western blotting by probing with both anti-flagellin type A and
B antibodies. A representative Western blot showing 11 of the
20 strains used in this study is presented in Fig. 1. The majority
of mucoid P. aeruginosa strains from our collection lacked
flagellin, indicating that they lacked the ability to express fla-
gella. Of the 20 CF isolates tested, 14 (70%) were mucoid and
nonflagellated, whereas 6 were mucoid and expressed flagellin.
For the remainder of the study, representatives of the mucoid,
nonflagellated subgroup of P. aeruginosa CF isolates were
used.
Mucoid, nonmotile CF isolates contain mutations in mucA.
It has been shown that approximately 80% of mucoid P. aerugi-
nosa CF isolates harbor a mutation in mucA, which encodes an
anti-sigma factor that controls AlgT activity (24). We wanted
to determine if there was a correlation between the mucA
status and the inhibition of flagellin expression in mucoid,
nonflagellated P. aeruginosa CF isolates. To address this, we
amplified and sequenced mucA in three flagellated and five
nonflagellated mucoid CF isolates. In all strains lacking flagel-
lin, we observed mutations in mucA (data not shown). In three
of these, the mutation was identical to that observed in FRD1
(mucA22) and involved the loss of a G residue, which yields a
premature stop codon and thus a truncated MucA (24). In
each of the mucoid, flagellated CF isolates, no mutation was
detected in the mucA gene. This suggests that the AlgT-medi-
ated inhibition of flagellum synthesis requires the inactivation
of mucA and subsequent deregulation of AlgT activity.
AlgT mediates the negative regulation of flagellum biosyn-
thesis in mucoid, nonmotile CF isolates. Previous work has
shown that in the mucoid, nonmotile CF isolate FRD1
(mucA22), AlgT is required for the inhibition of flagellum
synthesis (23). Therefore, we were interested in determining
whether this regulatory pathway is common among mucoid,
nonflagellated P. aeruginosa isolates. We first generated algT
mutants of several mucoid, nonmotile CF isolates. This was
accomplished by culturing mucoid, nonmotile P. aeruginosa
isolates under limiting oxygen conditions (17, 48). To identify
algT mutants, the arising motile variants were complemented
with algT. Subsequently, we amplified the algT gene of each
mutant. Consistent with previous observations (17), the algT
sequencing results revealed an algT29 mutation, which resulted
in a Tyr at codon 29 being changed to Cys. The static-growth-
derived algT mutants were used in subsequent experiments
comparing isogenic AlgT and AlgT.
To determine whether the AlgT-mediated inhibition of fla-
gellum expression is conserved among mucoid, nonmotile CF
FIG. 1. Flagellin expression of mucoid P. aeruginosa CF isolates. A
representative Western blot of whole-cell lysates was derived from P.
aeruginosa strains. Lane 1, control for flagellin A serotype; lane 2,
control for flagellin B serotype; lane 3, fliC mutant WFPA50; lanes 4
to 14, mucoid CF isolates. The results indicated that 70% of the strains
tested were mucoid and lacked flagellin.
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isolates, we compared the flagellin expression of mucoid, non-
flagellated CF isolates and that of their isogenic algT mutants
(Fig. 2). The results showed that while the mucoid, nonmotile
parental strains clearly lacked flagellin (lanes 2, 4, and 6),
flagellin expression was restored in the algT mutants (lanes 3,
5, and 7). All algT mutants analyzed expressed type B flagellin.
In addition, the algT mutants tested exhibited flagellum-medi-
ated swimming motility. When these mutants were comple-
mented with algT, alginate production was restored, and flagel-
lar motility and flagellin expression were abolished (data not
shown). These results designate AlgT as a regulator of flagel-
lum biosynthesis in mucoid, nonmotile CF isolates of P. aerugi-
nosa.
Microarray analysis of isogenic AlgT and AlgT P. aerugi-
nosa strains. Upon identification of AlgT as a regulator of
flagellum expression, we wanted to determine its target(s)
within the complex flagellar hierarchy. Previous work in our
laboratory showed that the AlgT-mediated control of flagellum
biosynthesis within the flagellar hierarchy occurs downstream
of rpoN, which codes for an alternative sigma factor involved in
flagellum expression, and upstream of fliC, which encodes
flagellin, the major component of the flagellar filament (23). In
order to identify candidate AlgT-regulated genes, we per-
formed single replicate microarray analysis of the mucoid, non-
flagellated strain FRD1 (mucA22) and its isogenic nonmucoid,
flagellated algT mutant, FRD440 (mucA22 algT::Tn501), by
using a P. aeruginosa whole-genome microarray (Affymetrix).
The summary of the entire microarray data set is provided in
Table S2 in the supplemental material. Based on our analysis,
we identified 552 candidate AlgT-controlled genes out of the
5,666 predicted open reading frames included on the microar-
ray (see Table S1 in the supplemental material). As expected,
the microarray data showed significantly higher mRNA levels
for alginate biosynthetic and regulatory genes in the presence
of AlgT. In contrast, the mRNA levels of many flagellar genes
were significantly reduced in the AlgT strain FRD1. P. aerugi-
nosa contains approximately 50 genes encoding structural and
assembly components of the flagellum or proteins of the che-
motaxis machinery, which are clustered in three regions of the
bacterial chromosome (15). The most pronounced inhibitory
effect of AlgT was seen in flagellar genes clustered in region I,
which contains regulatory and structural genes involved in fla-
gellum expression. These include fleQ and fleSR, coding for
essential regulators of flagellum biosynthesis (15), and fliC,
which encodes the main structural component of the flagellar
filament. In region I, mRNA levels of fliC were 16-fold lower
in the AlgT strain than in the AlgT strain. The fliI and fliH
genes, which code for an ATPase and a regulator of the
ATPase protein, respectively (15), were least affected by AlgT.
The genes clustered in region II and III were moderately
affected by AlgT and were downregulated between two- and
threefold. The effect of AlgT on mRNA levels of known flagel-
lar genes is summarized in Fig. 3.
In addition to alginate and flagellar genes, a number of other
genes encoding unidentified transcriptional regulators and
two-component systems as well as toxins and antibiotic resis-
tance proteins were also affected by AlgT (see Table S1 in the
supplemental material). The data obtained by microarray anal-
ysis indicate that AlgT exerts broad-range regulatory effects on
approximately 6% of the P. aeruginosa genome, with alginate
and flagellar genes accounting for one-fifth of AlgT-regulated
genes.
While the single replicate microarray analysis provided an
overview of the AlgT effect on flagellar genes, we wanted to
validate the obtained results and performed RT-PCR as an
independent assay. We chose a representative for each class of
the flagellar genes and analyzed mRNA levels in isogenic
AlgT and AlgT P. aeruginosa strains (Fig. 4). The class I
gene fleQ was downregulated threefold in the presence of
AlgT, which was comparable to the array data (3.2-fold). The
class II gene fliE, which encodes a flagellar hook-basal body
complex protein (15), was repressed 1.9-fold (array data, 2.9-
fold) in the AlgT strain. Expression of flgC, which codes for
FIG. 2. AlgT inhibits flagellum biosynthesis. Whole-cell lysates of
mucoid, nonmotile P. aeruginosa CF isolates and their isogenic algT
mutants were separated by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis and examined for flagellin expression by Western blot-
ting with flagellin B antiserum. Lane 1, PAO1 (flagellin B control);
lanes 2 and 3, mucoid, nonmotile CF isolate 1, AlgT and AlgT,
respectively; lanes 4 and 5, mucoid, nonmotile CF isolate 2, AlgT and
AlgT, respectively; lanes 6 and 7, mucoid, nonmotile CF isolate 3,
AlgT and AlgT, respectively. As a loading control, a second gel was
simultaneously prepared and processed by Coomassie blue staining
and contained equivalent amounts of total protein.
FIG. 3. Organization of P. aeruginosa flagellar genes and the effect
of AlgT on their expression. Microarray analysis comparing transcrip-
tomes of isogenic AlgT and AlgT P. aeruginosa strains was per-
formed. Significantly lower levels of mRNA were observed for the
majority of flagellar genes. fleQ, which encodes the flagellar master
switch, was identified as the highest target of AlgT within the flagellar
hierarchy. Arrows indicate the direction of transcription of the flagel-
lar operons.
7958 TART ET AL. J. BACTERIOL.
a basal body rod protein (15) and belongs to the third class of
flagellar genes, was reduced 7.3-fold in the presence of AlgT
(array data, 6.2-fold). Class IV genes flgM, which codes for an
anti-sigma factor (22), and fliC were downregulated 2.5- and
15.8-fold, respectively, which also corresponded to the array
data (2.1- and 16.1-fold, respectively). As an internal control,
we evaluated expression of the omlA gene, which encodes a
constitutively expressed outer membrane lipoprotein (34). This
was validated by the array data and the RT-PCR assay. Thus,
the RT-PCR data provided strong support for the microarray
data and independently confirmed the role of AlgT in the
inhibition of flagellar gene expression.
AlgT inhibits the expression of the flagellar key regulator
fleQ. The results obtained from the microarray and the RT-
PCR analysis showed that the majority of flagellar genes were
downregulated in the presence of AlgT and that fleQ repre-
sented the highest target within the flagellar hierarchy. Since
FleQ ultimately drives the expression of all other known flagel-
lar genes (8, 15) with the exception of fliA, it is likely that the
observed repression of other flagellar genes occurs as a result
of the inhibition of fleQ. To further evaluate the AlgT effect on
fleQ, we fused the fleQ promoter with a promoterless lacZ and
integrated the fusion into the chromosomes of the mucoid,
nonflagellated strain FRD1 and the isogenic algT mutant
FRD440. As an internal control, we generated lacZ fusions to
the constitutive omlA promoter (34). The activities of the fleQ
promoter in the AlgT and AlgT strains were determined
with -galactosidase assays (33). In FRD1, fleQ promoter ac-
tivity is significantly reduced in the presence of AlgT (Fig. 5).
To determine whether this AlgT-mediated inhibition of fleQ is
conserved among mucoid, nonmotile CF isolates, we intro-
duced fleQ-lacZ fusions into two mucoid, nonflagellated CF
isolates and their isogenic algT mutants. The results of this
experiment revealed that, as in FRD1, the fleQ promoter ac-
tivity in these mucoid, nonmotile CF isolates was reduced in
the presence of AlgT (Fig. 5).
Negative control of fleQ by AlgT is sufficient to inhibit P.
aeruginosa flagellum biosynthesis. While we demonstrated that
high levels of active AlgT result in the negative transcriptional
regulation of fleQ, we also needed to determine whether this
inhibition of fleQ is sufficient for the loss of flagellum expres-
sion. We hypothesized that if the repression of fleQ by AlgT is
sufficient to abolish flagellum biosynthesis, increased expres-
sion of FleQ in mucoid, nonmotile cells should overcome the
inhibitory AlgT effect. We constructed pAT6 by placing fleQ
under the control of an arabinose-inducible promoter. Plasmid
pAT6 was introduced into the chromosomes of FRD1 and the
fleQ deletion strain PAKQ. The resulting strains, FRD2700
and PAKQ/pAT6, were grown in the absence and presence of
arabinose and examined for flagellin expression by Western
blot (Fig. 6). In the absence of the inducer, FRD2700 did not
express flagellin (Fig. 6A, lane 3). However, as the concentra-
tion of inducer was increased, a dose response increase in
expression of flagellin was observed (6A, lanes 4 to 7). The
results obtained for PAKQ/pAT6 mirrored those observed
for FRD2700 (data not shown).
To determine if elevated levels of FleQ also promote mo-
tility, we performed motility assays using soft agar with and
without arabinose. In the absence of the inducer, FRD2700
was nonmotile, as indicated by the lack of a motility zone
FIG. 4. RT-PCR comparing flagellar gene expression in isogenic
AlgT and AlgT P. aeruginosa strains. RT-PCR was performed on
representatives of the four classes of flagellar genes to compare their
mRNA levels in isogenic AlgT and AlgT P. aeruginosa strains. The
RT-PCRs were separated on an agarose gel, and band intensities were
compared using a Kodak Image Station 2000RT system. omlA was
included as constitutive control (34). Shown are the averages of four
independent experiments and standard deviations. Differences (n-fold)
in mRNA levels for both microarray and RT-PCRs are indicated.
FIG. 5. AlgT inhibits fleQ expression. fleQ::lacZ fusions were inte-
grated into the chromosomes of mucoid, nonmotile P. aeruginosa CF
isolates and their isogenic algT mutants at the neutral attB site. Pro-
moter activity was measured with -galactosidase assays using ONPG
as a substrate and determined as amounts of ONPG hydrolyzed min1
as a function of cell density. omlA::lacZ fusions were included as a
constitutive control (34). Shown are the averages of four independent
experiments and standard deviations.
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observed on the motility plates (Fig. 6B, section III). In con-
trast, overexpression of FleQ in FRD2700 restored flagellum-
mediated motility, resulting in a zone of motility (32 mm)
comparable to that observed for the motile control, PAO1 (33
mm) (Fig. 6B, sections IV and I, respectively). Similar results
were obtained when the motility of strain PAKQ/pAT6 was
examined on soft agar plates with or without arabinose (data
not shown). In addition to performing these experiments, we
examined FRD2700 by TEM to determine whether the bacte-
ria were expressing a normal polar flagellum. Cells grown in
the absence of the inducer did not express flagella (Fig. 6C,
panel I). In the presence of the 0.1% arabinose, FRD2700
expressed a single polar flagellum characteristic for P. aerugi-
nosa (Fig. 6C, panel II). Upon addition of higher concentra-
tions of arabinose, FRD2700 became hyperflagellated. Flagella
were observed on both poles of the cells, and flagellar numbers
varied between three and eight (Fig. 6C, panel III is a repre-
sentative). The mucoid phenotype of FRD2700 was unaltered
upon induction of flagellar motility, which implies that the
mucoid and the motile phenotypes are not mutually exclusive.
DISCUSSION
In the United States, approximately 30,000 individuals suffer
from the recessive genetic disorder cystic fibrosis. Pulmonary
complications as a result of this disease remain the primary
concern for these patients, as they are exceedingly difficult to
treat, especially upon colonization with P. aeruginosa (13). Two
critical factors allowing P. aeruginosa to persist in the airways
of CF patients include its ability to form biofilms and its con-
version to a mucoid phenotype, which is frequently accompa-
nied by the loss of flagellum expression. Previous work per-
formed in our laboratory as well as this study shows a link
between alginate biosynthesis and flagellum expression, which
are inversely regulated by the alternative sigma factor AlgT
(23). While the role of AlgT in alginate expression is well
defined (24, 38), its function in the negative control of flagel-
lum biosynthesis remains to be elucidated. In this report, we
show that expression of flagellar genes is significantly reduced
in the presence of AlgT. The fleQ gene, a crucial regulator in
the flagellar regulon, was identified as the highest target of
AlgT within the flagellar hierarchy. In addition, we show that
increased expression of FleQ in mucoid, nonflagellated P.
aeruginosa CF isolates reverses the AlgT-mediated inhibition
of flagellum expression. Taken together, our data indicate that
AlgT represses P. aeruginosa flagellum biosynthesis by inhibit-
ing expression of the flagellar regulator fleQ.
While it has been suggested that there is no correlation
between mucoidy and loss of flagellar motility in CF isolates
(32), we observed that 70% of mucoid P. aeruginosa strains
from CF patients did not express flagellin. These data indi-
cated that in a subgroup of mucoid CF isolates, flagellum
expression and alginate expression are inversely regulated. In
most cases (80%), the conversion of P. aeruginosa to a mucoid
phenotype in the CF lung is due to an inactivating mutation in
mucA which results in deregulation of the alternative sigma
factor AlgT (24). We observed that each of the mucoid CF
isolates that lacked flagellin harbored a mutation in mucA.
Sequencing of mucA in the mucoid, flagellated CF isolates of
P. aeruginosa revealed that this gene was intact. In the latter
case, overexpression of alginate is MucA independent and may
involve the secondary, RpoN-dependent pathway (12).
It has been suggested that the mucoid phenotype and the
lack of flagella provide P. aeruginosa with a selective advantage
in the CF lung (32, 38). The copious quantities of exopolysac-
charide form a barrier that shields the bacteria from inflam-
matory mediators as well as antibiotics. Moreover, infection of
airway epithelial cells with mucoid P. aeruginosa results in
increased expression of epithelial cellular genes with antiapop-
totic effects. The presence of alginate not only attenuates host
responses but also aids in the bacterial circumvention of host
FIG. 6. Inhibition of fleQ by AlgT is sufficient for the loss of fla-
gellum expression. (A) Western blot of whole-cell lysates. Lane 1, type
B flagellin; lane 2, FRD1; lane 3, FRD2700 (FRD1 with fleQ under the
control of an arabinose-inducible promoter) with no arabinose; lanes 4
to 7, FRD2700 plus arabinose (lane 4, 0.1% arabinose; lane 5, 0.5%
arabinose; lane 6, 1.0% arabinose; lane 7, 2.5% arabinose). (B) Mo-
tility assay on 0.3% agar. (I) PAO1 (motile control); (II) FRD1 (non-
motile control); (III) FRD2700 with no arabinose; (IV) FRD2700 plus
0.1% arabinose. (C) TEM of negatively stained P. aeruginosa.
(I) FRD2700 with no arabinose; (II) FRD2700 plus 0.1% arabinose;
(IV) FRD2700 plus 2.5% arabinose.
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defenses (14). Flagella, on the other hand, are potent inducers
of inflammatory mediators (14, 27, 28, 37). While flagella are
essential in the colonization of the CF lung (6, 7, 42), they may
become detrimental as the disease progresses. Thus, both loss
of the flagellar structure and overproduction of alginate are
advantageous for P. aeruginosa, as those allow it to evade the
immune system and facilitate its persistence in the CF lung.
The inhibition/regulation of flagellum biosynthesis in re-
sponse to external conditions is commonly observed among
gram-negative bacteria. Usually, if the environmental condi-
tions impose stress on the cells, flagellum synthesis is reduced
or eliminated (2, 30). These conditions include nutrient avail-
ability, temperature, ionic composition, pH, and surface inter-
actions (3, 30, 31, 40). Similar effects of environmental condi-
tions have also been observed for Salmonella enterica serovar
Typhimurium (3, 31). In both E. coli and Salmonella serovar
Typhimurium, environmental conditions have been shown to
regulate flagellum expression at the level of transcription.
H-NS, a nucleoid protein, and a wide variety of transcription
factors and two-component response regulators often modu-
late motility (1, 11, 21). In Bordetella bronchiseptica, the two-
component system BvgAS is involved in the downregulation of
flagella in response to external stimuli, such as MgSO4 or
nicotinic acid (4). Therefore, it is possible that the FleQ-de-
pendent repression of flagellum expression we uncovered in P.
aeruginosa also occurs in response to environmental stress sig-
nals. In this context, Wolfgang et al. demonstrated that P.
aeruginosa reduces flagellum synthesis when grown in the pres-
ence of mucopurulent respiratory liquids derived from CF
patients. Upon exposure to CF airway fluid, an 80% reduction
of fliC mRNA was observed, indicating the presence of a re-
pressive signal in this environment (45).
We have shown that AlgT mediates alginate and flagellum
biosynthesis in P. aeruginosa in a reciprocal fashion. There is
evidence in other bacterial species, including E. coli (36) and
Vibrio cholerae (44), for a similar inverse control of flagellum
and exopolysaccharide biosynthesis. In E. coli, downregulation
of flagellum synthesis is often accompanied by an increase of
colanic acid exopolysaccharide expression (36). In V. cholerae,
mutations in flrA and flrC, which code for regulatory genes of
flagellum biosynthesis, resulted in the induction of exopolysac-
charide synthesis (44). These examples suggest that the coor-
dinate regulation of exopolysaccharide production and flagel-
lum expression may be a common feature of gram-negative
bacterial species.
The assembly of a functional flagellum requires the coordi-
nate expression of approximately 50 genes and is energetically
costly. In E. coli, as much as 2% of the total biosynthetic energy
expenditure is required for the synthesis and function of fla-
gella (31). Flagellum genes are organized in an ordered regu-
latory cascade in which the expression of later genes requires
the presence of earlier gene products. In peritrichously flagel-
lated bacterial species, such as E. coli or Salmonella serovar
Typhimurium, flagellum biosynthesis follows a three-tiered hi-
erarchy, with flagellar genes being grouped into classes I to III.
In contrast, monoflagellates, such as P. aeruginosa and Vibrio
parahaemolyticus, regulate flagellum biosynthesis with a four-
tiered cascade (classes I to IV) (5). In this report, we observed
that the repression of flagellum synthesis in P. aeruginosa oc-
curs by transcriptional inhibition of fleQ, a class I gene. The
fleQ gene is the earliest in the transcriptional regulatory hier-
archy and controls expression of all remaining genes of the
flagellar regulon with the exception of fliA. As fleQ forms the
master switch of the P. aeruginosa flagellar regulatory network,
its reduced expression would ultimately have an inhibitory
effect on downstream genes within the cascade. This is similar
to the shutoff of flagellum synthesis in E. coli, where the class
I master operon flhDC is transcriptionally repressed (40, 41).
Flagella are common among gram-negative bacteria and
allow the microorganisms to reach favorable envirommental
conditions and avoid detrimental environmental conditions.
Thus, bacteria can successfully compete with other microbial
species and colonize ecological niches optimal for their growth.
Interestingly, flagella are also involved in virulence, adhesion,
colonization, and biofilm formation. Stressful external condi-
tions affect flagellar motility in similar fashions and often result
in the inhibition of flagellum biosynthesis. The ability to tightly
regulate the expression of flagella provides bacteria with the
capacity to adapt to their changing environments. In opportu-
nistic pathogens such as P. aeruginosa, for instance, the re-
quirements for flagellum expression vary depending on their
mode of growth within their host or within the environment
(free swimming versus biofilm), and in each case, such expres-
sion or loss thereof provides the bacterium with a selective
advantage. To persist in the CF lung, P. aeruginosa must be
able to circumvent the immune defenses of the host, and re-
pression of flagellum biosynthesis aids in accomplishing this
goal. In mucoid, nonflagellated CF isolates of P. aeruginosa,
flagellum expression is shut off as the result of the transcrip-
tional inhibition of fleQ by the alternative sigma factor AlgT. A
detailed knowledge of the mechanism of this inhibitory process
in P. aeruginosa not only may be useful in understanding the
adaptability of this opportunistic pathogen to its various envi-
ronments but may also elucidate similar pathways in other
flagellated gram-negative microorganisms.
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